+33 1 76 70 47 90 / creativ@creativ-ceutical.com

[PSS21] Cost-Effectiveness of A 0.2 mg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK

[PSS21] Cost-Effectiveness of A 0.2 mg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK

2017 ISPOR 20TH ANNUAL EUROPEAN CONGRESS

Beiderbeck, A. | Aballéa, S. | Pochopien, M. | Maman, K. | Zur, R.M. | Toumi, M. | Volume: 20, Issue: 9, Pages: A804, A,
https://www.doi.org/10.1016/j.jval.2017.08.3068